Portal Vein Tumor Thrombus Clinical Trials

13 clinical trials for Portal Vein Tumor Thrombus across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus — RECRUITING · PHASE2
BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases — RECRUITING · PHASE2
TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT — RECRUITING · NA
HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT — COMPLETED · NA
Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus — OTHER · PHASE1
Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT — OTHER · PHASE4
Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus — OTHER · PHASE3
Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus — OTHER · PHASE2
Sorafenib Plus Toripalimab for Unresectable HCC With Portal Vein Tumor Thrombus — OTHER · PHASE1
Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion — COMPLETED · PHASE2
A Trial to Compare Surgery With Sorafenib for Hepatic Celluler Cancer With Portal Vein Tumor Thrombosis — OTHER · PHASE4
Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients — COMPLETED · PHASE2
Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus — COMPLETED · NA

Refine this search